NovaBay Cleared to Market NeutroPhase Wound Cleanser in China

NovaBay Pharmaceuticals, a California company, reported that its NeutroPhase® Skin and Wound Cleanser was cleared for China sale by the CFDA. NeutroPhase is a non-antibiotic anti-infective product. Two years ago, China Pioneer Pharma Holdings acquired rights to market NeutroPhase in China. Since then, Pioneer has become NovaBay's largest shareholder. The approval triggers a $625,000 milestone from Pioneer to NovaBay. More details.... Stock Symbols: (NYSE: NBY) (HK: 01345) Share this with colleagues: // //